Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03173053Terminated
Randomised, open-label trial in Staphylococcus aureus colonization (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Proportion of patients totally eradicated for S. aureus at 1 year. Started Feb 2018; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03173053.